検索結果
-
April 10 (Reuters) - Legal technology and artificial intelligence company CS Disco has hired a new chief executive following the exit of its former leader amid sexual misconduct allegations last year. The Austin-based electronic discovery software maker said Wednesday that Eric Friedrichsen will start as president and CEO on April 29. He takes over from interim CEO and board member Scott Hill, who has held the role since co-founder Kiwi Camara's abrupt departure last September. なんだ、Kiwiはセクハラで訴えられてCEOやめたんか、、、、 なにやっとんKiwi
-
トランスポゾンの社長すごい経歴ですね。 ↓ Eckard was chairman of a number of companies until their successful exits including Peninsula Pharmaceuticals (sold to Johnson & Johnson, 2005), Cerexa (sold to Forest Laboratories, 2007), NovaCardia (sold to Merck, 2007), Calixa (sold to Cubist Pharmaceuticals, 2009) and Ocera Therapeutics (sold to Mallinckrodt, 2017). He was also a board member of Conforma Therapeutics (sold to Biogen-IDEC, 2006), Cabrellis Pharmaceuticals (sold to Pharmion, 2006) and Tobira Therapeutics (sold to Allergan, 2016).
もう一度 トランスポゾン社社長…
2024/05/21 11:07
もう一度 トランスポゾン社社長の経歴をおさらいしましょう。 ↓ Eckard was chairman of a number of companies until their successful exits including Peninsula Pharmaceuticals (sold to Johnson & Johnson, 2005), Cerexa (sold to Forest Laboratories, 2007), NovaCardia (sold to Merck, 2007), Calixa (sold to Cubist Pharmaceuticals, 2009) and Ocera Therapeutics (sold to Mallinckrodt, 2017). He was also a board member of Conforma Therapeutics (sold to Biogen-<span id="stockNameLink" data-stockcode="6652.T">IDEC</span>, 2006), Cabrellis Pharmaceuticals (sold to Pharmion, 2006) and Tobira Therapeutics (sold to Allergan, 2016).